Genmab — Juli 2019

[StockBull]

Morn https://penge.borsen.dk/artikel/1/384595/foer_markedet_aabner_genmab_i_fokus_-_hvordan_ser_salgstallene_ud.html?utm_source=forside&utm_campaign=nyhed_01 Børsen idag

[E_L]

the exact words from that Q&A Sukkeralf refers to;

[E_L]

Sukkeralf The PD-L1/4-1BB BsAb seems to have overtaken CD40/4-1BB bsAb - why ? Do the
4-1BB arm come from the same antibody or are they different moieties ?

[E_L]

Andrew Carlsen We are fortunate enough to have two exciting programs with our partner BioNTech
and the reason for PD-L1/41BB being slightly further progressed has to do with
prioritization and resource allocation. With regards to the 4-1BB arm we have not
disclosed this to the public

[E_L]

i don´t think he is that negative, maybe we´ll still see it , also keeping in mind BioNTech also just got funding (if that was the issue)

[bibob]

Teva aktien på laveste niveau siden 90 erne. Nu mindre værd end Genmab. ;-). https://medwatch.dk/Medicinal___Biotek/article11503235.ece

[bibob]

Kaare har så mange rynker i panden at han kan skrue hatten på.

[Mickey_Mouse]

er dette en gammel nyhed - har ikke set det før

[Mickey_Mouse]

Milliardaftale sender Genmab i kapløb mod farmakæmpe og gammel rival

Genmab har indgået en mulig milliardalliance om udvikling af ny type immunterapi mod kræft, som blandt andre den tyske medicinalkoncern Boehringer Ingelheim og en af det danske biotekselskabs tidligere ærkerivaler også satser på.

(medwatch.dk)

[Mickey_Mouse]

pensionist - tak for info

[peter12]

Det må være denne ? https://endpts.com/boehringer-ingelheim-is-thinking-in-blockbuster-terms-as-it-throws-its-hat-into-the-ever-widening-cd47-ring/

[StockBull]

(edge.media-server.com)

[henrik48]

Så skal vi bare vente 15 minutter

[Smadsen128]

Var det ikke 12.15

[henrik48]

Jeg læste det som 12:45

[bibob]

12.45

[jkj]

detber vist godt

[AaBforever]

Sewr ud til der er gode nyheder på vej..:-)

[jkj]

det er vist godt

[bikube]

Kursen kører da op med expresfart nu